Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

SecurityEVH / Evolent Health, Inc.
InstitutionAperio Group, LLC
Latest Disclosed Ownership17,476 shares
Latest Disclosed Value $ 280,000
Aperio Group, LLC reports 3.98% increase in ownership of EVH / Evolent Health, Inc.

On February 5, 2021 - Aperio Group, LLC filed a 13F-HR form disclosing ownership of 17,476 shares of Evolent Health, Inc. (US:EVH) valued at $280,140 USD as of December 31, 2020. The entity filed a previous 13F-HR on November 6, 2020 disclosing 16,807 shares of Evolent Health, Inc.. This represents a change in shares of 3.98% during the quarter. The current value of the position is $73,749 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2021-02-05 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 17,476 669 3.98 280 33.97 0.0008
2020-11-06 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 16,807 1,217 7.81 209 88.29 0.0007
2020-08-13 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 15,590 3,364 27.52 111 68.18 0.0004
2020-05-05 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 12,226 693 6.01 66 -36.54 0.0003
2020-02-13 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 11,533 -739 -6.02 104 18.18 0.0004
2019-11-06 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 12,272 7,183 141.15 88 120.00 0.0003
2019-07-30 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 5,089 5,089 40 0.0002
2019-05-03 2018-12-31 13F/A-1 EVOLENT HEALTH INC CL COMMON 30050B101 0 -10,688 -100.00 0 -100.00
2019-05-06 2018-09-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 10,688 644 6.41 304 44.08 0.0013
2018-10-17 2018-09-30 13F EVOLENT HEALTH INC CL COMMON 30050B101 10,688 644 304
2019-05-06 2018-06-30 13F/A-1 EVOLENT HEALTH CL A 30050B101 10,044 10,044 211 0.0010
2018-07-30 2018-06-30 13F EVOLENT HEALTH INC CL COMMON 30050B101 10,044 211
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.